comparemela.com

Latest Breaking News On - ப்ளூம்பெர்க் எலி லில்லி இணை - Page 1 : comparemela.com

Lilly Cuts Forecast After U S Covid Drug Order Cancelled

Lilly Cuts Forecast After U.S. Covid Drug Order Cancelled Apr 28 2021, 5:25 AM April 27 2021, 9:05 PM April 28 2021, 5:25 AM (Bloomberg) Eli Lilly & Co. cut the high end of its 2021 forecast after the U.S. canceled an order for the drugmaker’s solo Covid-19 antibody to focus on its combination treatment. (Bloomberg) Eli Lilly & Co. cut the high end of its 2021 forecast after the U.S. canceled an order for the drugmaker’s solo Covid-19 antibody to focus on its combination treatment. Adjusted earnings will top out at $8 a share, Indianapolis-based Lilly said Tuesday in a statement, down from an earlier maximum of $8.40. The company shaved the high end of its 2021 revenue forecast to $27.6 billion from $28 billion.

Lilly Covid Antibody Combo Gets U S Emergency Authorization

Lilly Covid Antibody Combo Gets U.S. Emergency Authorization Bloomberg 2/10/2021 Riley Griffin © Bloomberg Eli Lilly & Co. corporate headquarters stand in Indianapolis, Indiana, U.S., on Monday, May 21, 2012. (Bloomberg) Eli Lilly & Co.’s combination antibody drug for Covid-19 was cleared for emergency use by U.S. regulators, providing doctors with a treatment option that is expected to be better able to combat new coronavirus mutations. The Food and Drug Administration authorized the treatment for use in Covid-positive adults and children 12 and older who are at high risk of developing severe forms of the disease or progressing to the hospital, according to a fact sheet posted Tuesday by the agency.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.